See also this year's filing and all EDGAR filings for this company.
PDF Report 0001549595_2026_Nurix_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001549595, Nurix Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 606,819,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 22,490,000 |
| 3 | remainder_Assets | 58,826,000 |
| 4 | LiabilitiesCurrent | 86,471,000 |
| 5 | LiabilitiesNoncurrent | 62,917,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 67,223,429 |
| 9 | ResearchAndDevelopmentExpense | 585,236,544 |
| 10 | remainder_Expenses | 590,743 |
| 11 | remainder_Revenues | 104,034,147 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 263,767 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 688,135,000 |
| 1 | Liabilities | 149,388,000 |
| 2 | Expenses | 653,050,716 |
| 3 | Revenues | 104,034,147 |
| 4 | StockholdersEquity | 538,747,000 |
| 5 | NetIncome | -549,016,569 |
| 6 | ComprehensiveNetIncome | -548,884,686 |
| 7 | BaseVar | 797,435,815 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.49 |
| 9 | EconomicCapitalRatio | 2.67 |